Stroke Trial, Recruiting NCT04477330 Sponsor: University of Illinois at Chicago Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04477330
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • People who have had their first stroke affecting one side of the brain, with the stroke occurring more than 3 months ago
  • People who still have walking difficulties affecting one side of the body as a result of their stroke (such as an abnormal walking pattern)
  • People who are able to walk for 5 minutes at their own pace, with or without a walking aid such as a cane
  • People whose walking speed is slower than 1.2 metres per second
  • People whose lower limb movement and motor function falls within a specific range on a clinical assessment scale called the Fugl-Meyer Motor Score (a score between 15 and 30) (confirm with trial site)
  • People who have at least 5 degrees of upward ankle movement, which is needed to complete a specific ankle movement task used in the trial (confirm with trial site)

Who may not be able to join:

  • People with severe osteoporosis
  • People whose lower limb movement is significantly limited due to muscle or joint stiffness (contractures)
  • People with notably increased muscle stiffness in the ankle, as measured by a clinical scale called the Modified Ashworth Scale (a score above 2) (confirm with trial site)
  • People whose anti-spasticity medications (medicines used to reduce muscle stiffness) are not stable or are being changed during the study period
  • People with reduced sensation in the lower limb, as measured by the Fugl-Meyer Sensory Assessment Scale (a score below 6) (confirm with trial site)
  • People with heart, lung, or metabolic conditions such as irregular heartbeat, uncontrolled high blood pressure, uncontrolled diabetes, or chronic lung disease
  • People with unhealed pressure sores or an ongoing infection
  • People with significant difficulties with memory, thinking, or communication that may prevent them from understanding or completing the study tasks, as assessed by a cognitive screening tool called the Mini-Mental State Examination (a score below 21) (confirm with trial site)
  • People whose stroke affected the brainstem or cerebellum (specific regions at the base and back of the brain)
  • People who do not pass a supervised exercise stress test conducted before the trial begins
  • People who have an implanted cardiac pacemaker (a device fitted in the chest to regulate heartbeat)
  • People who have any metal implants in the head or face
  • People who experience unexplained, recurring headaches
  • People with a history of seizures or epilepsy
  • People currently taking medications that may increase brain excitability or lower the threshold for seizures
  • People with skull abnormalities or fractures
  • People who have had a concussion within the last 6 months
  • People who are currently pregnant
  • People with skin sensitivity or allergies that affect the scalp or skin
  • People with a history of contact dermatitis (a skin reaction caused by touching certain substances)
  • People with a history of allodynia (pain from normally non-painful stimuli) or hyperalgesia (increased sensitivity to pain)
  • People with any other skin or scalp condition that could be made worse by electrical stimulation applied to the scalp

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sangeetha Madhavan, University of Illinois at Chicago

Phone: 3123552517

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
1 September 2020
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Walking speed with 10 meter walk test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov